MOSAIC : A global study of the clinical, humanistic and economic burden of geographic atrophy in patients and caregivers
Purpose The purpose of the study was to explore the impact of visual impairment from geographic atrophy (GA) on patients and caregivers, focusing on clinical, humanistic and economic burdens. Methods MOSAIC was a noninterventional, cross‐sectional study comprising a two‐stage method to assess burden of disease on patients aged ≥60 years with GA secondary to age‐related macular degeneration and unpaid caregivers across the United Kingdom, Australia, Canada, France and Germany. Patients completed the 25‐item National Eye Institute Visual Function Questionnaire (NEI VFQ‐25); caregivers completed the Zarit Burden Interview (ZBI) and the Caregiver Indirect and Informal Care Cost Assessment Questionnaire (CIIQ). Both groups completed novel items developed for this study. Results GA negatively affected patient mobility and independence, especially related to driving (mean NEI VFQ‐25 driving subscale score: 23.1/100), with substantial effects on distance and near activities. Caregiving was considered a burden by 58% of caregivers, with greater burden for those caring for a parent than a partner (mean ZBI scores: 35.5 vs. 20.1, respectively). Financial concerns affected 44% of patients and 39% of caregivers. More than a quarter of caregivers altered their living arrangements. A moderate correlation was found between NEI VFQ‐25 near activities subscale score and self‐reported frequency of need for assistance ( r = 0.52, p < 0.0001) and between self‐reported reading ability and NEI VFQ‐25 mental health subscale score ( r = −0.53, p < 0.0001). Conclusion The MOSAIC study confirms profound impacts of GA on patients' and caregivers' daily activities, independence and mental health. The findings emphasise the need for treatment options and support strategies to alleviate challenges faced by patients with GA.
Authors
- Renaud Desgraz
- Sophie J. Bakri (ORCID: https://orcid.org/0000-0002-0887-3194)
- Sujata P. Sarda (ORCID: https://orcid.org/0000-0003-3729-9539)
- Roy Schwartz (ORCID: https://orcid.org/0000-0003-3487-5713)
- Winfried M. K. Amoaku (ORCID: https://orcid.org/0000-0001-5028-7984)
- Stéphane Quéré (ORCID: https://orcid.org/0000-0001-8832-6053)
- Jared S. Nielsen (ORCID: https://orcid.org/0000-0003-4321-1978)
- Michele Intorcia
- Christiana B Dinah (ORCID: https://orcid.org/0000-0002-0815-4771)
- Caroline R. Baumal (ORCID: https://orcid.org/0000-0002-3651-8210)
- Manal M’Hari
- Daniel Lee Jones (ORCID: https://orcid.org/0000-0003-3749-2443)
- Thibaud Alin
- Danielle E. Altman
- Beverly Lui
Institutions
- Biogen (United States) (US)
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Mayo Clinic (US)
- University of Nottingham (GB)
- Wellesley College (US)
- London North West Healthcare NHS Trust (GB)
- Wolfe Eye Clinic (US)
- Queen's Medical Centre (GB)
- Moorfields Eye Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- Acta Ophthalmologica
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1111/aos.70279
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00